Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchodilator Properties of V0162 in Asthma
NCT01951222Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Sep 2013
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of (R)-mequitazine in asthma, sponsored by Pierre Fabre Laboratories. Started Sep 2013; status: completed.
02
Drugs
(R)-mequitazine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01951222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951222.